Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|June 17, 2016
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA TrialGurjit S Kaeley, Amy M Evangelisto, Midori J Nishio, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA studyArthur Kavanaugh, Roy M Fleischmann, Paul Emery, et al.
The Journal of Rheumatology|October 19, 2010
Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitisMartin Rudwaleit, Katherine Gooch, Beat Michel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?Katherine Gooch, David Feeny, Robert L Wong, et al.
The Journal of Rheumatology|March 11, 2009
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitisMartin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, et al.
Annals of the Rheumatic Diseases|February 20, 2014
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trialGerd-Rűdiger Burmester, Alan J Kivitz, Hartmut Kupper, et al.
Rheumatology and Therapy|March 26, 2018
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA TrialGurjit S Kaeley, Daryl K MacCarter, Janak R Goyal, et al.
Rheumatology (Oxford, England)|March 4, 2009
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusionMartin Rudwaleit, Ignazio Olivieri, Kyriaki A Boki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateGurjit S Kaeley, Midori J Nishio, Janak R Goyal, et al.
The Journal of Rheumatology|November 19, 2013
Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extensionEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
Pageof 5